Drug prices increase: What’s the real reason behind 6500% rise?
Drug prices increase is alarming, with some prices soaring by 6500%. Discover the reasons behind this shocking trend.
Drug prices increase is alarming, with some prices soaring by 6500%. Discover the reasons behind this shocking trend.
Raltegravir tablets launch offers a new treatment option for patients in the US with 180-day exclusivity.
Stroke prevention drug news highlights Bayer’s first global approval in China, promising enhanced treatment options for patients.
Qftilia therapy approval is a significant advancement for haemophilia patients in India, ensuring better healthcare options.
Cancer drug price cap set at 30% aims to reduce costs for patients and improve access to vital medications.
FDA approval of WELTRUZA marks a significant achievement for Medincell in the pharmaceutical industry.
Milestone Pharmaceuticals stock remains steady at $0.92 following China approval, showing potential for growth in the pharmaceutical market.
Medical consumable price gaps are alarming, as highlighted by Maharashtra FDA Chief IAS Tukaram Mundhe’s findings.
